123 related articles for article (PubMed ID: 2510081)
1. Quantitative bone scanning in the diagnosis of aluminium osteomalacia.
Worth DP; Smye SW; Robinson PJ; Davison AM; Will EJ
Nephrol Dial Transplant; 1989; 4(8):721-4. PubMed ID: 2510081
[TBL] [Abstract][Full Text] [Related]
2. Dialysis osteomalacia: clinical aspects and physiopathological mechanisms.
Drüeke T; Cournot-Witmer G
Clin Nephrol; 1985; 24 Suppl 1():S26-9. PubMed ID: 3915957
[TBL] [Abstract][Full Text] [Related]
3. Newcastle bone disease in Hong Kong: a study of aluminum associated osteomalacia.
Chan MK; Varghese Z; Li MK; Wong WS; Li CS
Int J Artif Organs; 1990 Mar; 13(3):162-8. PubMed ID: 2189835
[TBL] [Abstract][Full Text] [Related]
4. Acute epidemic aluminium osteomalacia secondary to water supply contamination.
O'Brien AA; Moore DP; Keogh JA
Ir J Med Sci; 1990 Mar; 159(3):71-3. PubMed ID: 2361822
[TBL] [Abstract][Full Text] [Related]
5. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
Jarava C; Armas JR; Palma A
Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
[TBL] [Abstract][Full Text] [Related]
6. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
[TBL] [Abstract][Full Text] [Related]
7. Dialysate aluminium concentration and renal bone disease.
Walker GS; Aaron JE; Peacock M; Robinson PJ; Davison AM
Kidney Int; 1982 Feb; 21(2):411-5. PubMed ID: 7070002
[TBL] [Abstract][Full Text] [Related]
8. Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.
Charhon SA; Chavassieux PM; Meunier PJ; Accominotti M
Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1613-4. PubMed ID: 3924189
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcaemic osteomalacia due to aluminium toxicity.
Boyce BF; Fell GS; Elder HY; Junor BJ; Elliot HL; Beastall G; Fogelman I; Boyle IT
Lancet; 1982 Nov; 2(8306):1009-13. PubMed ID: 6127501
[TBL] [Abstract][Full Text] [Related]
10. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
Charhon SA; Chavassieux P; Chapuy MC; Accominotti M; Traeger J; Meunier PJ
Presse Med; 1986 Jan; 15(2):55-9. PubMed ID: 2935857
[TBL] [Abstract][Full Text] [Related]
11. [The role of aluminum in the development of osteomalacia in patients on chronic hemodialysis].
Adamiec R; Uzar J
Pol Arch Med Wewn; 1988 Jan; 79(1):3-12. PubMed ID: 3275167
[TBL] [Abstract][Full Text] [Related]
12. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
Balabán D; Simícková J; Kubátko J; Syrovátka P
Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999
[TBL] [Abstract][Full Text] [Related]
13. Aluminium-related osteomalacia: response to reverse osmosis water treatment.
Smith GD; Winney RJ; McLean A; Robson JS
Kidney Int; 1987 Jul; 32(1):96-101. PubMed ID: 3626303
[TBL] [Abstract][Full Text] [Related]
14. Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.
O'Brien AA; Moore DP; Keogh JA
Ir J Med Sci; 1990 Mar; 159(3):74-6. PubMed ID: 2361823
[TBL] [Abstract][Full Text] [Related]
15. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
Visser WJ; Van de Vyver FL
Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
[TBL] [Abstract][Full Text] [Related]
16. The bone scan in patients with aluminium-associated bone disease.
Botella J; Gallego JL; Fernandez-Fernandez J; Sanz-Guajardo D; de Miguel A; Ramos J; Franco P; Enriques R; Sanz-Moreno C
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():403-9. PubMed ID: 3991532
[TBL] [Abstract][Full Text] [Related]
17. Serum type I procollagen peptide: a non-invasive index of bone formation in patients on haemodialysis?
Hamdy NA; Risteli J; Risteli L; Harris S; Beneton MN; Brown CB; Kanis JA
Nephrol Dial Transplant; 1994; 9(5):511-6. PubMed ID: 8090331
[TBL] [Abstract][Full Text] [Related]
18. Aluminum osteopathy.
Cournot-Witmer G
Contrib Nephrol; 1984; 38():59-64. PubMed ID: 6713901
[No Abstract] [Full Text] [Related]
19. Treatment of dialysis osteomalacia with desferrioxamine.
Brown DJ; Dawborn JK; Ham KN; Xipell JM
Lancet; 1982 Aug; 2(8294):343-5. PubMed ID: 6124756
[TBL] [Abstract][Full Text] [Related]
20. Quantitative radionuclide scanning in metabolic bone disease.
Meindok H; Rapoport A; Oreopoulos DG; Rabinovich S; Meema HE; Meema S
Nucl Med Commun; 1985 Mar; 6(3):141-8. PubMed ID: 3158846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
